Kristi Norris

Kristi Norris is an accomplished professional in regulatory strategy, currently serving as the VP of Regulatory Strategy at Hyloris Pharmaceuticals since August 2021, following a similar role at Camargo Pharmaceutical Services from January 2013 to July 2021. With a diverse background in scientific and regulatory documentation, Kristi has led FDA meetings, supervised teams, and ensured high-quality submissions to regulatory agencies. Kristi's early career included research roles at the National Institutes of Health, where significant contributions to cancer research and mitochondrial biology were made, culminating in a PhD in Biochemistry and Molecular Genetics from The George Washington University. Additionally, Kristi has held part-time editing positions and has experience in developing gene therapies and vaccines. Education includes a business degree from Duke University's Fuqua School of Business and a BS in Biology from the College of Charleston.